Gonadotropin-Induced Steroidogenesis in Alzheimer's Disease
Author Information
Author(s): Kate M Webber, Douglas M Stocco, Gemma Casadesus, Richard L Bowen, Craig S Atwood, Laura A Previll, Peggy L R Harris, Xiongwei Zhu, George Perry, Mark A Smith
Primary Institution: Case Western Reserve University
Hypothesis
Hormones of the hypothalamic-pituitary-gonadal (HPG) axis, especially age-related increases in gonadotropins, play a key role in Alzheimer's disease pathogenesis.
Conclusion
The study suggests that luteinizing hormone (LH) may induce potentially pathogenic signaling in Alzheimer's disease through steroidogenic pathways.
Supporting Evidence
- StAR protein was increased in the cytoplasm of hippocampal neurons in Alzheimer's brains compared to controls.
- StAR expression colocalized with LH receptor expression in neurons.
- Increased LH levels in Alzheimer's patients suggest a link to steroidogenesis.
Takeaway
This study found that a protein involved in making hormones is higher in the brains of people with Alzheimer's, which might be linked to the disease.
Methodology
The study used immunocytochemical methods to examine StAR protein levels in brain tissue from Alzheimer's patients and age-matched controls.
Limitations
The study is limited by the small sample size and the specific focus on hippocampal tissue.
Participant Demographics
Participants included 16 individuals with Alzheimer's disease (ages 67–96) and 12 age-matched controls (ages 66–86).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website